Naghavi-Behzad, M.; Bjerg Petersen, C.; Vogsen, M.; Braad, P.-E.; Grubbe Hildebrandt, M.; Gerke, O.
Prognostic Value of Dual-Time-Point 18F-Fluorodeoxyglucose PET/CT in Metastatic Breast Cancer: An Exploratory Study of Quantitative Measures. Diagnostics 2020, 10, 398.
https://doi.org/10.3390/diagnostics10060398
AMA Style
Naghavi-Behzad M, Bjerg Petersen C, Vogsen M, Braad P-E, Grubbe Hildebrandt M, Gerke O.
Prognostic Value of Dual-Time-Point 18F-Fluorodeoxyglucose PET/CT in Metastatic Breast Cancer: An Exploratory Study of Quantitative Measures. Diagnostics. 2020; 10(6):398.
https://doi.org/10.3390/diagnostics10060398
Chicago/Turabian Style
Naghavi-Behzad, Mohammad, Charlotte Bjerg Petersen, Marianne Vogsen, Poul-Erik Braad, Malene Grubbe Hildebrandt, and Oke Gerke.
2020. "Prognostic Value of Dual-Time-Point 18F-Fluorodeoxyglucose PET/CT in Metastatic Breast Cancer: An Exploratory Study of Quantitative Measures" Diagnostics 10, no. 6: 398.
https://doi.org/10.3390/diagnostics10060398
APA Style
Naghavi-Behzad, M., Bjerg Petersen, C., Vogsen, M., Braad, P.-E., Grubbe Hildebrandt, M., & Gerke, O.
(2020). Prognostic Value of Dual-Time-Point 18F-Fluorodeoxyglucose PET/CT in Metastatic Breast Cancer: An Exploratory Study of Quantitative Measures. Diagnostics, 10(6), 398.
https://doi.org/10.3390/diagnostics10060398